Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute treatment of migraine. Reference standards of Ubrogepant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ubrogepant
Catalogue No.:PA 21 0250000
CAS :
Molecular Formula : C29H26F3N5O3
Molecular Weight : 549.55
(R)-2'-Oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic Acid
Catalogue No.:PA 21 0251000
Molecular Formula : C15H11N3O3
Molecular Weight : 281.27
(S)-1'-(tert-Butyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
Catalogue No.:PA 21 0251001
Molecular Formula : C18H19N3O
Molecular Weight : 293.37
(R)-1'-(tert-Butyl)-3-chloro-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
Catalogue No.:PA 21 0251002
Molecular Formula : C18H18ClN3O
Molecular Weight : 327.81
tert-Butyl ((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)carbamate
Catalogue No.:PA 21 0251004
Molecular Formula : C19H25F3N2O3
Molecular Weight : 386.42
tert-Butyl ((3R,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)carbamate
Catalogue No.:PA 21 0251005
tert-Butyl ((5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)(2,2,2-trifluoroethyl)carbamate
Catalogue No.:PA 21 0251006
Molecular Formula : C21H26F6N2O3
Molecular Weight : 468.44
tert-Butyl ((3R,5S,6R)-6-methyl-2-oxo-5-phenylpiperidin-3-yl)carbamate
Catalogue No.:PA 21 0251007
Molecular Formula : C17H24N2O3
Molecular Weight : 304.39
tert-Butyl ((3S,5S,6R)-6-methyl-2-oxo-5-phenylpiperidin-3-yl)carbamate
Catalogue No.:PA 21 0251008
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
